Brickell Biotech, Inc. is a development-stage pharmaceutical company focused on the acquisition, development and commercialization of innovative drug therapies for the treatment of skin diseases.
|
Date |
Amount |
Type |
Investors |
Valuation |
|---|---|---|---|---|
| 02/26/13 | $7,000,000 | Series B |
AMOREPACIFIC Ventures Palisade Concentrated Equity Partnership | undisclosed |
